University of Paris-Sorbonne-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2024

  1. Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study

    British Journal of Dermatology, Vol. 191, Núm. 3, pp. 419-427

2019

  1. CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis

    Bladder Cancer, Vol. 5, Núm. 2, pp. 159-169